← Back to Search

DOT Spectacle Lenses for Nearsightedness (ASH Trial)

Waterloo, Canada
N/A
Waitlist Available
Research Sponsored by SightGlass Vision, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Is under 17 years old and is accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document.
Has amblyopia in either eye or known to have any other binocular vision disorder, such as accommodative insufficiency.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 minutes
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to compare how quickly the eyes adjust focus between two types of glasses: DOT spectacle lenses and regular control spectacles."

See full description
Who is the study for?
This trial is for children and teenagers aged 6-18 who can read or understand consent documents, with nearsightedness within specific limits (+1.00D to -1.00D). They must be able to follow instructions and have no history of myopia treatment in the past year, amblyopia, binocular vision disorders, active eye diseases/infections, or systemic conditions like diabetes that could affect results.Check my eligibility
What is being tested?
The study aims to compare how DOT spectacle lenses versus control spectacles affect the lag of accommodation (eye's ability to focus on close objects) in young individuals with near-sightedness.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions (spectacle lenses), significant side effects are not anticipated. However, some participants might experience discomfort or visual strain while adjusting to new lens patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am under 17 and my parent or guardian can sign the consent form.
 show original
Select...
I have a lazy eye or another vision problem affecting both eyes.
 show original
Select...
I have an active eye disease or infection.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Best vision sphere

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment 1 - DOT PatternExperimental Treatment1 Intervention
Spectacle lens or treatment 1
Group II: Treatment 2 - Control SpectaclesActive Control1 Intervention
Comparator lens or control arm

Find a Location

Closest Location:Centre for Ocular Research and Education· Waterloo, Canada

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor
10 Previous Clinical Trials
1,063 Total Patients Enrolled
University of WaterlooOTHER
131 Previous Clinical Trials
220,870 Total Patients Enrolled
~7 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top